[CLINICAL EXPERIMENTATION OF A NEW ANTICOAGULANT DERIVATIVE OF DICOUMAROL: 3,3' METHYL-THIOPROPYLIDENE-BIS (4-HYDROXYCOUMARIN)].
D015110:4-Hydroxycoumarins; D000925:Anticoagulants; D001162:Arteriosclerosis Obliterans; D001281:Atrial Fibrillation; D035843:Biomedical Research; D003327:Coronary Disease; D003374:Coumarins; D001728:Dicumarol; D006973:Hypertension; D013927:Thrombosis; D014116:Toxicology
D015110:4-Hydroxycoumarins; D000925:Anticoagulants; D003374:Coumarins; D001728:Dicumarol; C068805:4-hydroxycoumarin
ANTICOAGULANTS; ARTERIOSCLEROSIS OBLITERANS; AURICULAR FIBRILLATION; CLINICAL RESEARCH; CORONARY DISEASE; COUMARINS; HYPERTENSION; THROMBOSIS; TOXICOLOGIC REPORT
EXP'ERIMENTATION CLINIQUE D'UN NOUVEL ANTICOAGULANT D'ERIV'E DU DICOUMAROL: LE 3,3' M'ETHYL-THIOPROPYLID'ENE-BIS (4-HYDROXYCOUMARINE)